Abstract: The present invention relates to a method for synthesizing a 2-((6-(hydroxymethyl)chromen-5-yl)oxy)-1-phenylethanone derivative. When the method is used, it is possible to effectively synthesize a 2-((6-(hydroxymethyl)chromene-5-yl)oxy)-1-phenylethanone derivative.
Type:
Grant
Filed:
July 20, 2020
Date of Patent:
December 2, 2025
Assignee:
GLACEUM INC.
Inventors:
Sang Ku Yoo, Ji Young Kim, Jung Woo Lee, Jeong Ho Lim, Ku Suk Kang, Jin Young Kim
Abstract: The present invention relates to a method for synthesizing a 3-phenyl-2,8-dihydropyrano[2,3-f]chromene derivative, which may be usefully used for synthesizing a pyranochromenyl phenol derivative, and when the derivative is used, the 3-phenyl-2,3,4,8,9,10-hexahydropyrano[2,3-f]chromene derivative may be effectively prepared.
Type:
Application
Filed:
April 3, 2019
Publication date:
February 11, 2021
Applicant:
GLACEUM INC.
Inventors:
Sang Ku YOO, Jin Wook CHUNG, In Geun JO, Ji Young KIM, Jeong Ho IM, Ku Suk KANG, Jin Young KIM
Abstract: Provided are a pyranochromenyl phenol derivative, a pharmaceutically acceptable salt thereof, or a solvate thereof. Also provided is a pharmaceutical composition for preventing or treating metabolic syndrome or inflammatory disease comprising same. The present invention is efficacious in preventing or treating metabolic syndrome or inflammatory disease and is chemically stable.
Type:
Grant
Filed:
December 23, 2014
Date of Patent:
October 10, 2017
Assignee:
Glaceum Inc.
Inventors:
Sang Ku Yoo, Jin Wook Chung, In Geun Jo, Jeong Ho Im, Ku Suk Kang, Jin Young Kim